Breaking News Instant updates and real-time market news.

MRK

Merck

$59.68

(0.00%)

04:55
05/15/18
05/15
04:55
05/15/18
04:55

Merck management to meet with Oppenheimer

Meeting to be held in New York on May 15 hosted by Oppenheimer.

  • 15

    May

  • 15

    May

  • 05

    Jun

  • 23

    Oct

MRK Merck
$59.68

(0.00%)

04/23/18
GSCO
04/23/18
UPGRADE
Target $73
GSCO
Conviction Buy
Goldman upgrades Merck to Buy, puts on Conviction List with $73 target
Goldman Sachs analyst Jami Rubin upgraded Merck to Buy from Neutral and added the shares to her firm's Conviction List. Rubin also upped her price target for the shares to $73 from $63. Merck closed Friday up 20c to $58.83. The analyst increased her estimates for Keytruda sales by $2B in 2021 and $4B in 2025. The narrative for Merck is "quickly changing with the success of Keytruda, driving a significant shift in product mix from a large primary care evolving into a specialty biopharma," Rubin tells investors in a research note. The analyst now sees "significant" margin upside from product mix shift with higher Keytruda sales than previously modeled. She believes Merck's operating margins could go from 32.5% in 2017 to 40% by 2025, with an inflection point beginning in the second half of 2018.
04/25/18
DBAB
04/25/18
NO CHANGE
DBAB
Hold
Merck may need to reassess animal health unit, says Deutsche Bank
While Merck (MRK) describes its animal health unit as a key growth driver and an important part of the company, it remains to be seen whether investors will continue to accept this as a reason for the business to remain within the company, Deutsche Bank analyst Gregg Gilbert tells investors in a research note. He believes the unit is potentially undervalued. Given Zoetis' (ZTS) success as a company and a stock, and Eli Lilly's (LLY) ongoing review of strategic options for its Elanco Animal Health business, Gilbert conducted a preliminary separation analysis of Merck's animal health unit. The analysis suggests that a separation could be meaningfully accretive to earnings. The analyst keeps a Hold rating on Merck.
04/26/18
BMOC
04/26/18
NO CHANGE
Target $70
BMOC
Outperform
Merck price target raised to $70 from $65 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Merck to $70 and kept his Outperform rating, forecasting a "mixed to net-positive" Q1 earnings report. The analyst notes the focus will likely fall on the core Keytruda and Januvia franchises as he raises his peak sales estimate for the former to $13B from $12B after KN-189 data, which he expects to be further supported by discussions at ASCO.
05/10/18
STFL
05/10/18
NO CHANGE
STFL
Hold
Exelixis pullback may create interesting entry point, says Stifel
After Exelixis (EXEL) and partner Roche (RHHBY) announced the Phase 3 IMblaze370 trial did not achieve statistical-significance on the primary efficacy endpoint evaluating the ability of a combination of a MEK inhibitor and anti-PD-L1 to improve overall survival in patients with microsatellite stable metastatic colorectal cancer, Stifel analyst Stephen Willey said he believes attrition in Exelixis shares might create an interesting entry point. The failure of IMblaze370 removes some of Exelixis' longer-term optionality and he expects topics of RCC growth/competition, label expansion, and longer-term cabozantinib exclusivity to remain core to the story going forward, said Willey who has a Hold rating on the stock. Array BioPharma (ARRY) also has Phase 1/2 development collaborations in place with both Bristol-Myers (BMY) and Merck (MRK) evaluating the MEK/PD-1 hypothesis in earlier-lines of MSS mCRC, noted Willey, who said he would "be opportunistic" on any weakness in its shares. He maintains a Buy rating on Array, which is down 5% in pre-market trading.

TODAY'S FREE FLY STORIES

INTC

Intel

$54.46

0.14 (0.26%)

09:06
05/23/18
05/23
09:06
05/23/18
09:06
Hot Stocks
Institut Curie, Intel collaborate for innovative bioinformatics tools »

Institut Curie and Intel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$85.74

-1.63 (-1.87%)

09:05
05/23/18
05/23
09:05
05/23/18
09:05
Hot Stocks
Breaking Hot Stocks news story on Lowe's »

Lowe's outgoing CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

LOW

Lowe's

$85.74

-1.63 (-1.87%)

, JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

09:05
05/23/18
05/23
09:05
05/23/18
09:05
Hot Stocks
Outgoing Lowe's CEO says Ellison the 'ideal' person to serve as next CEO »

Retiring Chairman and CEO…

LOW

Lowe's

$85.74

-1.63 (-1.87%)

JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Technical Analysis
Technical Take: SPDR S&P 500 ETF falls heading toward the open »

At time of writing the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.57

-0.69 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNS

Colony NorthStar

$5.78

-0.09 (-1.53%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Hot Stocks
Colony NorthStar announces additional $300M stock repurchase program »

Colony NorthStar…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

RMTI

Rockwell Medical

$5.94

-0.06 (-1.00%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Hot Stocks
Rockwell Medical board removes CFO after 'unauthorized' filing »

Rockwell Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$50.87

-1.4 (-2.68%)

, CAA

CalAtlantic

$0.00

(0.00%)

09:04
05/23/18
05/23
09:04
05/23/18
09:04
Recommendations
Lennar, CalAtlantic analyst commentary  »

Lennar price target…

LEN

Lennar

$50.87

-1.4 (-2.68%)

CAA

CalAtlantic

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

H

Hyatt

$80.47

-0.725 (-0.89%)

09:03
05/23/18
05/23
09:03
05/23/18
09:03
Hot Stocks
Hyatt opens Regency Shenzhen Airport Hotel »

Hyatt announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$61.40

-0.71 (-1.14%)

09:02
05/23/18
05/23
09:02
05/23/18
09:02
Hot Stocks
Abbott receives FDA approval for XIENCE Sierra »

Abbott announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil Circuit

$28.27

0.11 (0.39%)

09:02
05/23/18
05/23
09:02
05/23/18
09:02
Hot Stocks
Jabil expands in Israel with opening of Optics Technology Innovation Center »

Green Point, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$49.52

-0.47 (-0.94%)

, CBSH

Commerce Bancshares

$65.50

0.11 (0.17%)

09:01
05/23/18
05/23
09:01
05/23/18
09:01
Hot Stocks
Commerce Bancshares picks SS&C for CECL transition »

SS&C Technologies…

SSNC

SS&C

$49.52

-0.47 (-0.94%)

CBSH

Commerce Bancshares

$65.50

0.11 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 12

    Jun

AVID

Avid Technology

$5.00

-0.02 (-0.40%)

09:01
05/23/18
05/23
09:01
05/23/18
09:01
Hot Stocks
Avid Technology selected by Seneca College for media facilities upgrade »

Avid announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$80.43

-0.48 (-0.59%)

09:00
05/23/18
05/23
09:00
05/23/18
09:00
Recommendations
VF Corp. analyst commentary  »

VF Corp. removed as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFNX

Pfenex

$6.91

-0.05 (-0.72%)

08:59
05/23/18
05/23
08:59
05/23/18
08:59
Syndicate
Pfenex 6.8M share Spot Secondary priced at $5.50 »

Barclays and William…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

TIF

Tiffany

$102.26

-0.96 (-0.93%)

08:58
05/23/18
05/23
08:58
05/23/18
08:58
Hot Stocks
Tiffany says engagement category is at the core of the company »

Says paper flower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

IGT

International Game

$28.47

-1.28 (-4.30%)

08:56
05/23/18
05/23
08:56
05/23/18
08:56
Syndicate
International Game 18M share Secondary priced at $28.25 »

Credit Suisse acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 23

    May

TSC

TriState Capital

$27.05

0.2 (0.74%)

08:56
05/23/18
05/23
08:56
05/23/18
08:56
Syndicate
TriState Capital 2.2M share Spot Secondary priced at $25.90 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 23

    May

TJX

TJX

$87.50

2.84 (3.35%)

, M

Macy's

$33.12

-1.48 (-4.28%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Recommendations
TJX, Macy's, Kohl's, J.C. Penney analyst commentary  »

TJX results 'more…

TJX

TJX

$87.50

2.84 (3.35%)

M

Macy's

$33.12

-1.48 (-4.28%)

KSS

Kohl's

$60.60

-4.87 (-7.44%)

JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MU

Micron

$58.95

3.47 (6.25%)

, BAC

Bank of America

$30.89

0.34 (1.11%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Options
Notable open interest changes for May 23rd »

Tuesday's total…

MU

Micron

$58.95

3.47 (6.25%)

BAC

Bank of America

$30.89

0.34 (1.11%)

NXPI

NXP Semiconductors

$115.55

0.84 (0.73%)

CHK

Chesapeake

$4.54

-0.065 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

SLB

Schlumberger

$73.74

-1.28 (-1.71%)

, EOG

EOG Resources

$123.76

-3.69 (-2.90%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Conference/Events
UBS to hold a conference »

Global Oil & Gas…

SLB

Schlumberger

$73.74

-1.28 (-1.71%)

EOG

EOG Resources

$123.76

-3.69 (-2.90%)

HP

Helmerich & Payne

$70.74

-1.83 (-2.52%)

RRC

Range Resources

$15.45

-0.63 (-3.92%)

SWN

Southwestern Energy

$4.66

-0.07 (-1.48%)

TDW

Tidewater

$31.48

0.1 (0.32%)

NE

Noble Corp.

$5.86

-0.15 (-2.50%)

HES

Hess Corp.

$63.83

-1.42 (-2.18%)

TUSK

Mammoth Energy

$34.59

-1.27 (-3.54%)

DVN

Devon Energy

$41.82

-0.51 (-1.20%)

ICD

Independence Contract Drilling

$4.89

-0.25 (-4.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 30

    May

  • 25

    Jun

  • 27

    Jun

  • 20

    Jul

  • 19

    Aug

TMO

Thermo Fisher

$217.88

1.2 (0.55%)

08:55
05/23/18
05/23
08:55
05/23/18
08:55
Conference/Events
Thermo Fisher to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

CY

Cypress Semiconductor

$16.31

0.2 (1.24%)

08:54
05/23/18
05/23
08:54
05/23/18
08:54
Initiation
Cypress Semiconductor initiated  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 13

    Jun

  • 14

    Jun

TOL

Toll Brothers

$39.46

-4.14 (-9.50%)

08:52
05/23/18
05/23
08:52
05/23/18
08:52
Recommendations
Toll Brothers analyst commentary  »

Toll Brothers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$21.92

0.5 (2.33%)

08:51
05/23/18
05/23
08:51
05/23/18
08:51
Recommendations
Marvell analyst commentary  »

Marvell April quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

IDTI

Integrated Device

$32.49

0.41 (1.28%)

08:50
05/23/18
05/23
08:50
05/23/18
08:50
Initiation
Integrated Device initiated  »

Integrated Device…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.